BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26902636)

  • 1. Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells.
    Takada T; Takata K; Ashihara E
    J Physiol Sci; 2016 Sep; 66(5):387-96. PubMed ID: 26902636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma.
    Zhao H; Hu CY; Chen WM; Huang P
    Curr Med Sci; 2019 Jun; 39(3):403-409. PubMed ID: 31209810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers.
    Kubelt C; Peters S; Ahmeti H; Huhndorf M; Huber L; Cohrs G; Hövener JB; Jansen O; Synowitz M; Held-Feindt J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.
    Lim KS; Lim KJ; Price AC; Orr BA; Eberhart CG; Bar EE
    Oncogene; 2014 Aug; 33(35):4433-41. PubMed ID: 24077291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
    Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
    Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
    Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
    Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.
    Silva LS; Poschet G; Nonnenmacher Y; Becker HM; Sapcariu S; Gaupel AC; Schlotter M; Wu Y; Kneisel N; Seiffert M; Hell R; Hiller K; Lichter P; Radlwimmer B
    EMBO Rep; 2017 Dec; 18(12):2172-2185. PubMed ID: 29066459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocarboxylate transporters 1 and 4: expression and regulation by PPARα in ovine ruminal epithelial cells.
    Benesch F; Dengler F; Masur F; Pfannkuche H; Gäbel G
    Am J Physiol Regul Integr Comp Physiol; 2014 Dec; 307(12):R1428-37. PubMed ID: 25320343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
    Khan A; Valli E; Lam H; Scott DA; Murray J; Hanssen KM; Eden G; Gamble LD; Pandher R; Flemming CL; Allan S; Osterman AL; Haber M; Norris MD; Fletcher JI; Yu DMT
    Oncogene; 2020 Apr; 39(17):3555-3570. PubMed ID: 32123312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity.
    Gray AL; Coleman DT; Shi R; Cardelli JA
    Oncotarget; 2016 May; 7(22):32695-706. PubMed ID: 27127175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
    Quanz M; Bender E; Kopitz C; Grünewald S; Schlicker A; Schwede W; Eheim A; Toschi L; Neuhaus R; Richter C; Toedling J; Merz C; Lesche R; Kamburov A; Siebeneicher H; Bauser M; Hägebarth A
    Mol Cancer Ther; 2018 Nov; 17(11):2285-2296. PubMed ID: 30115664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.
    Hanson DJ; Nakamura S; Amachi R; Hiasa M; Oda A; Tsuji D; Itoh K; Harada T; Horikawa K; Teramachi J; Miki H; Matsumoto T; Abe M
    Oncotarget; 2015 Oct; 6(32):33568-86. PubMed ID: 26384349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
    Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
    Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
    Gurrapu S; Jonnalagadda SK; Alam MA; Ronayne CT; Nelson GL; Solano LN; Lueth EA; Drewes LR; Mereddy VR
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3282-3286. PubMed ID: 27241692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.
    Noble RA; Bell N; Blair H; Sikka A; Thomas H; Phillips N; Nakjang S; Miwa S; Crossland R; Rand V; Televantou D; Long A; Keun HC; Bacon CM; Bomken S; Critchlow SE; Wedge SR
    Haematologica; 2017 Jul; 102(7):1247-1257. PubMed ID: 28385782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
    Pivovarova AI; MacGregor GG
    Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.